F. Vincenti

2.0k total citations · 1 hit paper
54 papers, 1.6k citations indexed

About

F. Vincenti is a scholar working on Transplantation, Surgery and Infectious Diseases. According to data from OpenAlex, F. Vincenti has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Transplantation, 18 papers in Surgery and 11 papers in Infectious Diseases. Recurrent topics in F. Vincenti's work include Renal Transplantation Outcomes and Treatments (39 papers), Organ Transplantation Techniques and Outcomes (16 papers) and Cytomegalovirus and herpesvirus research (8 papers). F. Vincenti is often cited by papers focused on Renal Transplantation Outcomes and Treatments (39 papers), Organ Transplantation Techniques and Outcomes (16 papers) and Cytomegalovirus and herpesvirus research (8 papers). F. Vincenti collaborates with scholars based in United States, Spain and France. F. Vincenti's co-authors include Lars Bäckman, Susan Light, Mark D. Pescovitz, Ginny L. Bumgardner, John F. Neylan, Robert L. Kirkman, Robert S. Gaston, Philip F. Halloran, James F. Burdick and Alan Wilkinson and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Medicine and The Journal of Urology.

In The Last Decade

F. Vincenti

54 papers receiving 1.5k citations

Hit Papers

Interleukin-2–Receptor Blockade with Daclizumab to Preven... 1998 2026 2007 2016 1998 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
    1998 667 citations F. Vincenti, Robert L. Kirkman et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Vincenti United States 11 807 512 363 256 246 54 1.6k
Nina Tolkoff‐Rubin United States 18 613 0.8× 432 0.8× 287 0.8× 220 0.9× 208 0.8× 29 1.2k
Scott Ames United States 17 522 0.6× 500 1.0× 385 1.1× 254 1.0× 217 0.9× 33 1.3k
Yoshihiko Watarai Japan 21 799 1.0× 570 1.1× 277 0.8× 253 1.0× 401 1.6× 141 1.6k
John A. Daller United States 16 820 1.0× 702 1.4× 190 0.5× 359 1.4× 116 0.5× 45 1.5k
Maria Scolari Italy 18 404 0.5× 405 0.8× 199 0.5× 338 1.3× 223 0.9× 77 1.4k
Nilüfer Broeders Belgium 20 659 0.8× 526 1.0× 148 0.4× 357 1.4× 204 0.8× 48 1.5k
Marie‐Paule Emonds Belgium 26 1.2k 1.5× 1.0k 2.0× 461 1.3× 333 1.3× 296 1.2× 102 2.2k
H. H. Neumayer Germany 21 652 0.8× 365 0.7× 152 0.4× 305 1.2× 207 0.8× 54 1.4k
Antonio Schena Italy 18 716 0.9× 464 0.9× 188 0.5× 412 1.6× 167 0.7× 43 1.8k
Junchao Cai United States 22 1.4k 1.7× 1000 2.0× 632 1.7× 262 1.0× 277 1.1× 55 2.0k

Countries citing papers authored by F. Vincenti

Since Specialization
Citations

This map shows the geographic impact of F. Vincenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Vincenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Vincenti more than expected).

Fields of papers citing papers by F. Vincenti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Vincenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Vincenti. The network helps show where F. Vincenti may publish in the future.

Co-authorship network of co-authors of F. Vincenti

This figure shows the co-authorship network connecting the top 25 collaborators of F. Vincenti. A scholar is included among the top collaborators of F. Vincenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Vincenti. F. Vincenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wojciechowski, David, Sindhu Chandran, & F. Vincenti. (2014). Belatacept Conversion in Kidney Transplant Recipients for Prolonged DGF.. Transplantation. 98. 456–456. 1 indexed citations
2.
Wojciechowski, David, Allison B. Webber, Sindhu Chandran, Ryo Hirose, & F. Vincenti. (2014). Everolimus Conversion to Treat BK Virus Infection in Renal Transplant Recipients: Interim Analysis of a Pilot Study.. Transplantation. 98. 558–559. 2 indexed citations
3.
Friman, S., Wolfgang Arns, Björn Nashan, et al.. (2011). Sotrastaurin, a Novel Small Molecule Inhibiting Protein-Kinase C: Randomized Phase II Study in Renal Transplant Recipients. American Journal of Transplantation. 11(7). 1444–1455. 59 indexed citations
4.
Posselt, Andrew M., Melena D. Bellin, Mehdi Tavakol, et al.. (2010). Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody Efalizumab. American Journal of Transplantation. 10(8). 1870–1880. 99 indexed citations
5.
6.
Busque, Stéphan, Joseph R. Leventhal, Daniel C. Brennan, et al.. (2009). Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients. American Journal of Transplantation. 9(8). 1936–1945. 114 indexed citations
7.
Brennan, Todd V., Tom Florian Fuller, F. Vincenti, et al.. (2006). Living Donor Kidney Transplant Recipients and Clinical Trials: Participation Profiles and Impact on Post-Transplant Care. American Journal of Transplantation. 6(10). 2429–2435. 5 indexed citations
8.
Lauritano, E.C., Maurizio Gabrielli, A. Lupascu, et al.. (2005). Rifaximin dose‐finding study for the treatment of small intestinal bacterial overgrowth. Alimentary Pharmacology & Therapeutics. 22(1). 31–35. 101 indexed citations
9.
10.
Vincenti, F.. (2001). Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen. Transplantation Proceedings. 33(4). S11–S18. 8 indexed citations
11.
Ekberg, Henrik, Lars Bäckman, Gunnar Tufveson, et al.. (2000). Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis. Transplant International. 13(2). 151–159. 41 indexed citations
12.
Vincenti, F.. (1999). Potential of Daclizumab in Solid Organ Transplantation. BioDrugs. 11(5). 333–341. 6 indexed citations
13.
Vincenti, F., Robert L. Kirkman, Susan Light, et al.. (1999). Interleukin-2-Receptor Blockade With Daclizumab to Prevent Acute Rejection in Renal Transplantation. The Journal of Urology. 161(3). 1034–1035. 23 indexed citations
14.
Vincenti, F., Robert L. Kirkman, Susan Light, et al.. (1998). Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation. New England Journal of Medicine. 338(3). 161–165. 667 indexed citations breakdown →
15.
Nashan, Björn & F. Vincenti. (1998). SUCCESSFUL TRANSPLANTATION WITHOUT RECURRENCE IN HEMOLYTIC UREMIC SYNDROME OMITTING CALCINEURIN INHIBITORS FOR IMMUNOSUPPRESSION. Transplantation. 65(12). S92–S92. 1 indexed citations
16.
Sorof, Jonathan M., et al.. (1995). Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection.. PubMed. 60(11). 1215–9. 64 indexed citations
17.
Artero, Mary, Claude G. Biava, W Amend, Stephen J. Tomlanovich, & F. Vincenti. (1992). Recurrent focal glomerulosclerosis: Natural history and response to therapy. The American Journal of Medicine. 92(4). 375–383. 198 indexed citations
18.
Tomlanovich, S, W Amend, F. Vincenti, et al.. (1989). Immunologic alterations induced by donor-specific transfusion.. PubMed. 21(1 Pt 1). 1171–2. 2 indexed citations
19.
Vincenti, F., et al.. (1982). Blood transfusions before and on the day of transplantation: effects on cadaver graft survival.. PubMed. 14(2). 302–4. 5 indexed citations
20.
Vincenti, F., et al.. (1978). Cadaver kidney transplantation provided from one center within a large geographical region.. PubMed. 24. 270–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Tolkoff‐Rubin Breakdown of academic impact, for papers by Scott Ames Breakdown of academic impact, for papers by Yoshihiko Watarai Breakdown of academic impact, for papers by John A. Daller Breakdown of academic impact, for papers by Maria Scolari Breakdown of academic impact, for papers by Nilüfer Broeders Breakdown of academic impact, for papers by Marie‐Paule Emonds Breakdown of academic impact, for papers by H. H. Neumayer Breakdown of academic impact, for papers by Antonio Schena Breakdown of academic impact, for papers by Junchao Cai
Rankless by CCL
2026